- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04400227
Preventing Youth Substance Use With Family Talk
Pilot Study of Family Talk to Prevent Youth Substance Use
Study Overview
Study Type
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Participating parent is receiving treatment for substance use disorder
- Participating youth is between the ages of 12-25
- Participating youth has no diagnosis of substance use disorder
- Parent and youth are both comfortable communicating in English or Spanish
Exclusion Criteria:
- Acute family crisis, such as recent or current incarceration, divorce, adult return to substance use, or traumatic event
- Adult or youth with cognitive limitation or intellectual disability
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Youth-Parent Dyads
Participants will receive the Family Talk intervention and followup.
|
Family Talk is an evidence-based, parent-youth dyadic approach that uses psychoeducation and skills building to help families make meaning of a parent's adversity, increase resilience, and improve family functioning. The Family Talk model comprises two components: the first involves a series of cognitive-behavioral techniques to bolster problem solving and communication skills among family members; the second involves a facilitated family meeting to develop a shared narrative for discussing each family member's experience of the parent's illness. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in youth substance use based on the Timeline Followback Interview
Time Frame: baseline, 6 months
|
The Timeline Followback Interview (TLFB) will be used to estimate substance use.
It uses a calendar and asks the participant to indicate whether they used substances on each of the days listed for the last 3 months.
No score is given for the measure.
However, more days of use is associated with adverse health outcomes.
|
baseline, 6 months
|
|
Youth substance use based on the Timeline Followback Interview at 2 months
Time Frame: 2 months
|
The Timeline Followback Interview (TLFB) will be used to estimate substance use.
It uses a calendar and asks the participant to indicate whether they used substances on each of the days listed for the last 3 months.
No score is given for the measure.
However, more days of use is associated with adverse health outcomes.
|
2 months
|
|
Youth substance use based on the Timeline Followback Interview at 4 months
Time Frame: 4 months
|
The Timeline Followback Interview (TLFB) will be used to estimate substance use.
It uses a calendar and asks the participant to indicate whether they used substances on each of the days listed for the last 3 months.
No score is given for the measure.
However, more days of use is associated with adverse health outcomes.
|
4 months
|
|
Change in Youth substance use based on the Screening to Brief Intervention Tool
Time Frame: baseline, 6 months
|
The Screening to Brief Intervention instrument, or S2BI, is a 7-item instrument that asks about tobacco, alcohol, marijuana, prescribed drugs, inhalants, illegal drugs, and herbs/synthetic drugs.
Responses for each substance can be 'never', 'once or twice', 'monthly', of 'weekly or more'.
The result range from "no reported use," "lower risk," or "higher risk."
For the lower and higher risk categories the intervention provides guidance for developing an action plan for each response category.
|
baseline, 6 months
|
|
Youth substance use based on the Screening to Brief Intervention Tool at 2 months
Time Frame: 2 months
|
The Screening to Brief Intervention instrument, or S2BI, is a 7-item instrument that asks about tobacco, alcohol, marijuana, prescribed drugs, inhalants, illegal drugs, and herbs/synthetic drugs.
Responses for each substance can be 'never', 'once or twice', 'monthly', of 'weekly or more'.
The result range from "no reported use," "lower risk," or "higher risk."
For the lower and higher risk categories the intervention provides guidance for developing an action plan for each response category.
|
2 months
|
|
Youth substance use based on the Screening to Brief Intervention Tool at 4 months
Time Frame: 4 months
|
The Screening to Brief Intervention instrument, or S2BI, is a 7-item instrument that asks about tobacco, alcohol, marijuana, prescribed drugs, inhalants, illegal drugs, and herbs/synthetic drugs.
Responses for each substance can be 'never', 'once or twice', 'monthly', of 'weekly or more'.
The result range from "no reported use," "lower risk," or "higher risk."
For the lower and higher risk categories the intervention provides guidance for developing an action plan for each response category.
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Family Functioning based on the Family Problem Solving Communication Index
Time Frame: baseline, 2, 4, 6 months
|
The Family Problem Solving Communication (FPSC) Index is a 10-item questionnaire designed to assess both positive and negative patterns of family communication.
Answer choices are on a 4-point scale (0 = False, 1 = Mostly False, 2 = Mostly True and 3 = True).
The two subscales can be scored separately, with Incendiary Communication measuring negative attributes and Affirmative Communication measuring positive forms of communication.
|
baseline, 2, 4, 6 months
|
|
Family Functioning based on the Inventory of Parent and Peer Attachment
Time Frame: baseline, 2, 4, 6 months
|
Inventory of Parent and Peer Attachment (IPPA) is a validated questionnaire that consists of 25 items for the mother, 25 items for the father, and 25 items for the adolescent.
Three broad dimensions are assessed: degree of mutual trust, quality of communication, and extent of anger and alienation.
Answers are rated on a 5-point Likert scale from 1 (almost never or never) to 5 (almost always or always).
The IPPA is scored by reverse-scoring the negatively worded items and then summing the response values in each section.
|
baseline, 2, 4, 6 months
|
|
Depression
Time Frame: baseline, 2, 4, 6 months
|
Quick Inventory of Depressive Symptomatology is a 16-item questionnaire that measures rates of depression symptoms.
Each answer in the survey is worth between 0 and 3 points.
Severity of depression can be judged based on the total score.
1-5 = No depression 6-10 = Mild depression 11-15 = Moderate depression 16-20 = Severe depression 21-27 = Very severe depression.
|
baseline, 2, 4, 6 months
|
|
Perceived Stress
Time Frame: baseline, 2, 4, 6 months
|
Perceived Stress Scale (PSS) is a 10-item psychological instrument for measuring the perception of stress.
Answer choices range from 0 to 4 (0=Never and 4=Very Often).
PSS scores are obtained by reversing responses (e.g., 0 = 4, 1 = 3, 2 = 2, 3 = 1 & 4 = 0) to the four positively stated items (items 4, 5, 7, & 8) and then summing across all scale items with higher scores indicating higher levels of stress.
|
baseline, 2, 4, 6 months
|
|
Problem Solving
Time Frame: baseline, 2, 4, 6 months
|
The Social Problem-Solving Inventory - Revised (SPSI-R) has both a long form (52 questions) and short form (25 questions) and assesses individual's strengths and weaknesses in their problem-solving abilities.
The inventory has five component scales to assess problem-solving styles and solution generation: Positive Problem Orientation, Negative Problem Orientation, Rational Problem Solving, Impulsivity/Carelessness Style, Avoidance Style.
|
baseline, 2, 4, 6 months
|
|
Coping based on the Coping Self-Efficacy Scale
Time Frame: baseline, 2, 4, 6 months
|
The Coping Self-Efficacy Scale (CSES) is a 26-item measure of perceived self-efficacy for coping with challenges and threats.
The answer choices are a rating on an 11-point scale.
Anchor points on the scale are 0 ('cannot do at all'), 5 ('moderately certain can do') and 10 ('certain can do').
An overall CSES score is created by summing the item ratings with high scores indicate greater coping skills.
|
baseline, 2, 4, 6 months
|
|
Coping based on the Brief COPE
Time Frame: baseline, 2, 4, 6 months
|
The Brief COPE is a 28-item multidimensional measure of strategies used for coping or regulating cognitions in response to stressors.
There are 14 two-item subscales within the Brief COPE, and each is analyzed separately: (1) self-distraction, (2) active coping, (3) denial, (4) substance use, (5) use of emotional support, (6) use of instrumental support, (7) behavioral disengagement, (8) venting, (9) positive reframing, (10) planning, (11) humor, (12) acceptance, (13) religion, and (14) self-blame.
Respondents rate items on a 4-point Likert scale, ranging from 1 - "I haven't been doing this at all" to 4 - "I've been doing this a lot."
Each of the 14 scales is comprised of 2 items; total scores on each scale range from 2 (minimum) to 8 (maximum).
Higher scores indicate increased utilization of that specific coping strategy.
|
baseline, 2, 4, 6 months
|
|
Social support
Time Frame: baseline, 2, 4, 6 months
|
The Social Adjustment Scale-Self-Report (SAS-SR) 54-item measure that evaluates the efficacy of pharmacological treatments of mental disorders to provide an understanding of a client's satisfaction with his or her social situation.
Answer choices are on a 5-point Likert scale with higher scores indicating a better quality of life.
|
baseline, 2, 4, 6 months
|
|
Stressful Life Events
Time Frame: baseline, 2, 4, 6 months
|
The Stressful Life Events Screening Questionnaire (SLESQ) is a 13-item self-report measure that assesses lifetime exposure to traumatic events.
For each event, respondents are asked to indicate whether the event occurred ("yes" or "no"), their age at time of the event, as well as other specific items related to the event, such as the frequency, duration, whether anyone died, or was hospitalization, etc.
No score is given for the measure.
|
baseline, 2, 4, 6 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Caroline Kistin, MD MSc, Boston Medical Center
- Study Director: Scott Hadland, MD, Massachusetts General Hospital
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-38895
- K23DA045085 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
University of ArkansasNational Center for Advancing Translational Sciences (NCATS)RecruitingParenting | Substance Use Treatment | Perinatal Substance UseUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorders | Nicotine Use DisorderUnited States
-
Woebot HealthStanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)Active, not recruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Substance Use DisordersUnited States
-
Spark Biomedical, Inc.National Institute on Alcohol Abuse and Alcoholism (NIAAA); Baylor College... and other collaboratorsRecruitingSubstance Use Disorders | Alcohol Use Disorder | Alcohol Abuse | Substance Use Disorders Alcohol Use Withdrawal StateUnited States
Clinical Trials on Family Talk
-
Ersta Sköndal University CollegeRecruitingIllness TerminalSweden
-
Ersta Sköndal University CollegeCompleted
-
Mental Health Services in the Capital Region, DenmarkTrygFonden, Denmark; Sektion for Tværsektoriel forskning - Region HovedstadenActive, not recruitingChild | Parenting | Resilience | Mental Disorder | Prevention | FamilyDenmark
-
Ray HershbergerNational Heart, Lung, and Blood Institute (NHLBI); National Human Genome Research...Active, not recruiting
-
Ersta Sköndal University CollegeCompletedPalliative CareSweden
-
Ersta Sköndal University CollegeForteRecruiting
-
Brown UniversityNational Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)Recruiting
-
University of GuelphCanadian Institutes of Health Research (CIHR); Western University; Society of...Completed
-
JHSPH Center for Clinical TrialsNational Cancer Institute (NCI)Enrolling by invitationCancer | Mobile Application | Social Support (Formal and Informal)United States
-
Johns Hopkins UniversityCompleted